- Country: South Korea
- Summary: [Rfp1-1-1] Operation of an Infectious Disease Clinical Trial Consortium and Support System to Promote Infectious Disease Clinical Trials
- KRT Ref No: 133971952
- Deadline: 04 Mar 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 909090909
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN[Rfp1-1-1] Operation of an Infectious Disease Clinical Trial Consortium and Support System to Promote Infectious Disease Clinical Trials - Korea Tender
The INFECTIOUS DISEASE RESEARCH AND DEVELOPMENT FOUNDATION LINKED TO PAN-MINISTRY PRESCRIPTION STATIONS, a Government sector organization in South Korea, has announced a new tender for [Rfp1-1-1] Operation of an Infectious Disease Clinical Trial Consortium and Support System to Promote Infectious Disease Clinical Trials. This tender is published on KoreaTenders under KRT Ref No: 133971952 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-03-04.
The estimated tender value is KRW 909090909, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
